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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated (HA), community-associated (CA) and live-
stock-associated (LA) infections. Recently, the discovery of human and bovine MRSA isolates carrying a new mecA gene homologue,
mecALGA251 (now designated mecC), has caused concern because they are not detected by conventional, conﬁrmatory tests for MRSA.
Very little is known about their frequency, epidemiology and possible transmission between livestock and humans. In this study, the epi-
demiology of the mecC isolates in Denmark was investigated by screening the national collections of MRSA cases (from 1988 onwards)
and S. aureus bacteraemia cases (from 1958 onwards). Isolates carrying mecC were only recovered infrequently before 2003 (n = 2) but
now seem to be increasing, with 110 cases in 2003–2011. Clinical data on mecC-carrying MRSA demonstrated that mecC-MRSA were
primarily community-acquired (CA-MRSA) and affected persons typically living in rural areas, being older than other CA-MRSA patients.
Among 22 cases in Region Zealand, four reported contact with cattle and sheep. Two of these persons lived on farms with livestock
positive for mecC-carrying MRSA, sharing spa type (t843), MLVA (MT429) and PFGE pattern with the human isolates. These observa-
tions indicate that mecC-carrying MRSA can be exchanged between humans and ruminants.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a major
cause of hospital acquired (HA-MRSA) infections as well as
an increasing cause of infections in non-hospitalized persons
(community acquired, CA-MRSA) (1–3). Since 2006 detec-
tion of MRSA in livestock, especially pigs, but also in calves,
chickens, horses, turkey and dairy cattle, has shown that live-
stock constitute a reservoir of MRSA belonging to clonal
complex (CC) 398 (LA-MRSA), which can be transmitted to
humans (4–6). Interchange of isolates between the reservoirs
may be accomplished by adaptation to the host as well as to
differences in antibiotic pressure. Price et al. (6) suggested
that CC398 originated as methicillin susceptible in humans,
jumped to pigs, wherein methicillin resistance was acquired,
and is now seen re-infecting humans.
In 2011, a new mecA gene homologue, mecALGA251, was
found in isolates from both humans and dairy cattle (7). It
has been suggested by the International Working Group on
the Classiﬁcation of Staphylococcal Cassette Chromosome
(SCC) Elements (8) that the mecALGA251 gene should be
renamed mecC, and this term will be used herein. The
mecC-containing MRSA isolates were found to belong to lin-
eages typically reported in cattle (i.e. CC130, CC1943 and
sequence type (ST) 425), which indicated the existence of a
zoonotic MRSA reservoir (7). Bovine isolates belonging to
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CC130 and CC1943 have been found in the United King-
dom, Ireland, France and Sweden (7–10) (http://www.smit-
tskyddsinstitutet.se/nyhetsarkiv/2012/ny-variant-av-antibiotik
aresistent-bakterie and F. Laurent personal communica-
tion). However, in a Danish study of S. aureus isolated
from cattle, pigs and chicken, no such isolates were found
(11).
In humans, 11 mecC-positive CC130 isolates were
detected among a total of 12 691 (prevalence of 0.1%) in
Germany (12) and sporadic human cases have also been
detected in Norway, Sweden, Belgium and the Netherlands
(L. Marstein, S. Hagman, A. Petersson, O. Denise, personal
communications).
In Denmark, we suggested a frequency of mecC-positive
strains between 0.2 and 1% of all MRSA isolates, based on
initial ﬁndings of human isolates with spa type t843 (7). This
may, however, be an underestimate because these isolates
have not previously been recognized as MRSA and no sys-
tematic surveillance studies have been carried out as yet.
This study provides insight into the emergence, frequency
and epidemiology of mecC-containing strains in an MRSA
low-prevalence country. Investigations of individual cases fur-
ther substantiated the hypothesis of a zoonotic reservoir and
transmission to humans.
Materials and Methods
Setting
Denmark has 5.58 million inhabitants, in ﬁve different
regions: North Denmark (0.58 million), Central Denmark
(1.27 million), Southern Denmark (1.20 million), Zealand
0.82 million) and Capital (1.72 million) (http://www.statistics-
denmark.dk/, visited March 11, 2012). Since 1958, S. aureus
has been surveyed at the Staphylococcus reference labora-
tory (SRL) at Statens Serum Institut (SSI). A low prevalence
(<2%) of MRSA has been detected among Staphylococcus aur-
eus bacteraemia cases (SAB) since 1975. Nationwide surveil-
lance of SAB has been carried out since 1958 and for MRSA
since 1988. One isolate from each case has prospectively
been submitted to the SRL, where it has been typed, suscep-
tibility tested and stored. spa typing has been performed
since 2007 (n = 17 969) and on additionally selected isolates
prior to 2007 (n = 2116).
Search strategy
Staphylococcus aureus isolates were selected for this study
based on being phenotypic MRSA but negative for mecA
using conventional in-house PCR (13) from the national col-
lection of SAB isolates 1960–2011 (n = 45 000), the national
collection of MRSA irrespective of origin isolated between
1988 and 2011 (n = 7700), and a healthy nasal carriers in
2009–2010 (n = 403) (13,14). In addition, SAB and presumed
MRSA isolates routinely received in our laboratory after 1
August 2011 (n = 643) were included in the study. See
Table 1 for description of collections.
mecC detection and characterization of isolates
The isolates were conﬁrmed as mecC positive by a recently
developed multiplex PCR assay (16).
Isolates were spa-typed and subjected to MLST typing if
spa types were not previously directly linked to CC130,
TABLE 1. Description of Staphylococcus aureus bacterial collections included in the study
Bacterial collection Search strategy and conﬁrmation Use in the study
SAB 1960–2011 (n = 45 000)
Danish S. aureus bacteraemia isolates submitted voluntarily. All
isolates typed by various methods and tested for susceptibility
to antimicrobials. Clinical and epidemiological information
retrieved from hospital discharge summaries
Database search 1960–July 2011: (1) phenotypic MRSA, negative
for mecA—PCR for detection of mecC; (2) search for spa types
previously associated with mecC carriage.
From 1 August 2011 all isolates received were tested for the
presence of mecC.
Clinical and
bacteriological
information
MRSA 1988–2011 (n = 7700)
From 1988 to 31 October 2006, all MRSA were systematically
collected at SRL. From 1 November 2006, all new MRSA cases
were mandatory reportable and isolates were sent to SRL. All
isolates were spa typed and tested for susceptibility to
antimicrobials. Clinical and epidemiological information has been
retrieved for all MRSA isolates.
A subset consisting of mecA-positive S. aureus from 2007–2011
categorized as CA-MRSA (n = 2636)
Database search 1988–July 2011: phenotypic MRSA, negative for
mecA—PCR for detection of mecC
From 1 August 2011 all isolates received were tested for the
presence of mecC
Clinical and bacteriological
information
Clinical and bacteriological
information. Used for
comparison
Staphylococcus aureus from healthy carriers 2009–2010
Strain collections from:
Andersen et al. (13) (n = 325)
Fode et al. (14) (n = 78)
Search for spa types previously associated with mecC.
UK isolates
Positive mecC isolates from the UK (human = 2, animal = 2) Pulsed-ﬁeld gel
electrophoresis
Danish animal isolates
Positive mecC isolates from sheep (n = 3) and cow (n = 1) Pulsed-ﬁeld gel
electrophoresis
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CC2361 or ST425 (17,18). Selected isolates were subjected
to pulsed-ﬁeld gel electrophoresis (PFGE) and multi-locus
VNTR analysis (MLVA) as previously described (19, 20).
SCCmec typing was performed as previously described
(7,21). Antimicrobial susceptibility was determined using disc
diffusion according to EUCAST methodology for 12 antimi-
crobials (penicillin, cefoxitin, norﬂoxacin, erythromycin, clin-
damycin, kanamycin, tetracycline, linezolid, fusidic acid,
rifampicin, sulphamethoxazole-trimethoprim and mupirocin)
(http://www.eucast.org).
Clinical information
MRSA in humans became notiﬁable in Denmark on 1
November 2006. Because mecC-positive isolates previously
were deﬁned as borderline oxacillin-resistant or modiﬁed
S. aureus, no standardized notiﬁcation was made by the sub-
mitting hospitals. On such isolates, regular notiﬁcations were
received for all mecC-carrying isolates from 1 January 2010
onwards. From the notiﬁcations, reason for sampling (infec-
tion or carriage) and place of acquisition (HA, CA or travel,
or healthcare-associated with a community onset (HACO))
were registered. Acquisition was determined as previously
described based on the time of sampling after admission to
hospital (< or >48 h), travel activities and occupation (22). In
addition, contact with other MRSA-positive persons was reg-
istered. Residential county and Danish or foreign origin
(deﬁned as being born outside or having a parent who was
born outside of Denmark) was investigated through the Dan-
ish civil registration system. Clinical information for isolates
from before 2010 was retrieved from hospital discharge
summaries or general practitioners’ notes, when available.
In Region Zealand (820 000 inhabitants) and North Den-
mark (580 000 inhabitants), 22 and 12 mecC-positive persons
were contacted by the MRSA infection control nurse, at
Slagelse and Aalborg Hospitals, respectively, and interviewed
about occupation and contact with animals. If contact with
animals was conﬁrmed, animal samples were taken, when-
ever possible, from the animals after the owner’s informed
consent. Samples were taken from the muzzles/nostrils of
sheep, goats, cows, dogs, horses and rabbits. The time
between human and animal sampling was 3–12 months.
Presence of S. aureus was conﬁrmed by growth in selec-
tive broth (Tryptic Soy Broth + 7.5% NaCl), morphology on
5% horse blood agar (SSI Diagnostika, Hillerød, Denmark),
positive agglutination by Slidex Staph Plus (Biome´rieux,
Marcy l’Etoile, France) and detection of the spa gene frag-
ment.
The human mecC MRSA cohort was compared with other
MRSA cases from our database, using data from 1 January
2007 onwards (i.e. since MRSA became notiﬁable).
Statistics
Statistical signiﬁcance was assessed using the Fisher¢s exact
test and Student’s t-test, with a p value of <0.05 indicating
signiﬁcance.
Results
The retrospective search was made among all isolates in
Table 1. A total number of 87 were mecC-positive MRSA iso-
lates. Two mecC-positive isolates were from 1975 and 1992,
respectively. Prospective testing for presence of mecC in SAB
and presumed MRSA isolates during 5 months (1 August to
31 December 2011) identiﬁed 25 unique mecC-positive iso-
lates among 643 MRSA (3.9%). The combined annual inci-
dence between 2003 and 2011 was: n = 3, 7, 11, 12, 6, 5, 9,
21 and 36, respectively (Fig. 1). Clinical and microbiological
description of the mecC-positive isolates included in the
study is shown in supplementary Table S1. Compared with
the total number of MRSA in the period 2003–2011, mecC
constituted 112/6960 (1.5%), with an increasing tendency,
the frequency reaching 21/1097 (1.9%) and 36/1294 (2.8%) in
2010 and 2011, respectively (Fig. 1). By searching for isolates
with spa types related to carriage of mecC, we identiﬁed 12
MSSA isolates (t528, n = 11 and t1048, n = 1) among more
than 45 000 entries in our databases (<0.03%). No mecC-
positive isolates were found among healthy carriers
(n = 403, sampled in 2009 and 2010, Table 1).
Clinical information
In addition to the notiﬁcations received after 1 January 2010,
information regarding 40 patients before this date was
obtained on request; however, clinical information varied in
quality. Annotation of the reason for sampling was possible
for 95 cases: infection in 79 cases, screening in 10 cases and
another reason in six cases (Table 2). Infection was predomi-
nantly skin and soft tissue infections (SSTI) (n = 63); the
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FIG. 1. Number of total MRSA and mecC harbouring isolates/year.
E18 Clinical Microbiology and Infection, Volume 19 Number 1, January 2013 CMI
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, E16–E22
remainder were SAB (n = 8), postoperative wound infections
(n = 4), one urinary tract infection, and three that remained
unknown.
Epidemiological classiﬁcation into CA, HA, HACO or
imported cases was possible for 78 cases (n = 64, 3, 10 and
1 cases, respectively). Six patients who had MRSA carrying
mecC had been born, or had parents born, outside Denmark
(Iran, Norway, the Netherlands, Sweden, Thailand and the
USA).
As the majority of the mecC isolates were CA-MRSA, we
compared cases with mecA-positive CA-MRSA cases, 2007–
2011 (n = 2636) (Table 2). No differences were observed
between the two cohorts regarding gender (p 1.00, Fisher’s
exact test); however, CA-MRSA mecC patients were signiﬁ-
cantly older than other CA-MRSA cases (p <0.001, Student’s
t-test). Moreover, CA-MRSA-mecC patients had a signiﬁcantly
higher frequency of infections (p <0.001, Fisher’s exact test).
However, no signiﬁcant difference in the proportion of infec-
tions was seen from 2011 onwards when compared with
mecA-positive CA-MRSA cases, 2007–2011.
Typing and antimicrobial susceptibility testing of isolates
harbouring mecC
The mecC-carrying MRSA isolates could be grouped into
MLST clonal complexes CC130 (n = 98) and CC2361
(n = 14), based on spa typing and MLST of representative
isolates (n = 10). Two new MLST types were found, ST2173
(allelic proﬁle 18-313-260-18-235-223-5) and ST2174 (18-
313-279-18-7-223-5), both STs belonging to clonal complex
CC2361, to which other mecC-positive spa types already
belonged. spa typing revealed 19 different spa types
(Table 2), dominated by t843 belonging to CC130 (n = 70),
t528/CC130 (n = 9) and t978/CC2361 (n = 7). Several spa
types not previously reported to be mecC positive were
found to harbour mecC (CC130: t373, t528, t1048, t3218,
t3256, t3570, t5970, t9379 and CC2361: t2345, t3391,
t8835, t9395). blaZ, mecI and mecR speciﬁc for the SCCmec
XI were detected in all isolates, but ampliﬁcation of ccrA1
and ccrB3 failed for some isolates belonging to different spa
types. Except for one isolate resistant to norﬂoxacin, mecC
MRSA isolates only expressed resistance to beta-lactams. No
isolates carried the PVL gene (lukF-PV).
Rural distribution and relation to bovine or ovine reservoirs
mecC-positive isolates were found in all regions, with the
majority in more rural areas (n = 86) and only six isolates
from the Capital region (Fig. 2).
The highest number of cases was found in Region Zealand
and North Denmark (n = 29 and 15, respectively). In Region
Zealand, 14 were healthy carriers and the remaining had
infections: SSTI (n = 4), wound infections (n = 7), blood
(n = 2), urinary tract infections (n = 1), and unknown
(n = 1).
Twenty-two patients (22/29) from Region Zealand were
interviewed at follow-up about occupation and possible con-
tact with livestock animals.
In four cases contact with animals was reported.
Case 1: female, 53 years, with bacteraemia; teacher; living
on a small farm with two cows and a horse, only one cow
carried mecC MRSA in the nostrils. Case 2: female, 69 years,
TABLE 2. Comparison of MRSA-mecC and CA-MRSA patients and isolates (2007–2011)
mecC MRSA total
n = 112
mecC CA-MRSA
n = 64
CA-MRSA
n = 2636
Clinical
Gender ratio (F/M) 1.04 1.03 1.02
Average age (years) 51 (n = 110, 2 NA) 48 36***
Reason for sampling (n = 95)
Infection 79 (83%) 48 (75%) 55%***
Screen 10 (11%) 9 (14%) 39%
Other/NA 6 (6%) 7 (11%) 6%
Type of infection (n = 79) (n = 47)
SSTI 63 (80%) 42 (89%) 77%
Blood 8 (10%) 4 (10%) 1%
Urine 1 (1%) 1 (2%) 2%
Postoperative 4 (5%) – 0
Unknown 3 (4%) – 20%
Bacteriological
MLST CC (spa types) CC130 (n = 98) CC130 (n = 60) CC8, CC5, CC398, CC80, CC30, CC22,
CC1, CC45 and 17 otherst373, t528, t843, t1048, t1532, t1535, t1736,
t1773, t3218, t3256, t3570, t5970, t6220, t9397
t528, t843, t1048, t1773, t3256,
t3570, t6220
CC2361 (n = 14) CC2361 (n = 4)
t978, t2345, t3391, t8835, t9395 t978, t2345
PVL (%) 0 0 38
SCCmec type XI XI IV, V
Multiresistance (%)a 0 0 36
Bold: predominant spa type. NA: not available.
aResistance to three or more groups of antimicrobials in addition to beta-lactams.
***p <0.001
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with SSTI; nurse in old peoples’ home; living on a farm with
a herd of sheep and a dog, three of 10 sheep carried mecC
MRSA (t843) but not the dog.
Case 3 and 4: both male, 64 years, presenting with SSTI
and positive uriculture, respectively; working as butchers
(cattle); worked and lived apart and no animals were avail-
able for screening.
The mecC-carrying MRSA isolates from cows and sheep
in proximity to case 1 and case 2, respectively, had the
same spa type (t843) and MLVA proﬁle (MT429) as the
owners. MT429 was the predominant MLVA proﬁle found
among other humans in Region Zealand, as well as in other
regions. PFGE of the isolates conﬁrmed the similarity
between animal and human isolates; however, other t843
isolates from Region Zealand with no known contact with
these cases revealed similar patterns. The same was true
for isolates from the United Kingdom included as likely
outliers and the PFGE results were therefore inconclusive
(Fig. 3). Four persons infected with t843 isolates from
North Denmark reported contact with live cows. Subse-
quent screening of ten cows in the vicinity of three of
the patients revealed no MRSA but a single MSSA isolate
(t591-CC1).
Discussion
The discovery of MRSA carrying the mecC gene has caused
speculations about the origin, epidemiology and impact of
these isolates. In this study these questions were addressed
by searching the Danish S. aureus collections for isolates har-
bouring the mecC gene and collecting demographic and clini-
cal information from the affected patients. This search
revealed 112 such cases. The majority of isolates were found
in recent years and there has been an increase in numbers
and frequency to a total of 36, comprising 2.8% of all new
MRSA cases in 2011.
The national MRSA guidelines advocate eradication of
MRSA in carriers and close contacts, which means that a
large proportion of Danish MRSA cases (approximately 40%)
are found by active screening. This procedure has not been
practised systematically for MRSA being negative for mecA
before August 2011, meaning that the true prevalence of
mecC-carrying MRSA may be underestimated. This is compat-
ible with results of prospective testing since August 2011,
which showed a proportion of mecC-carrying MRSA of 3.9%
among new MRSA isolates. However, only 20% of these
cases were found by active screening, meaning that (i)
screening procedures still perform differently for mecC
MRSA cases compared with other MRSA cases, (ii) mecC-car-
rying MRSA isolates cause infections with a relatively higher
frequency or (iii) other preferred colonization niches exist
that were not screened. This difference may also explain
why a higher frequency of infection was found in the retro-
spective period compared with the situation after August
2011. Contacts with mecC-positive persons would then rou-
tinely have been screened and more non-infected carriers
would be detected. Countries with a low prevalence of
MRSA have the opportunity to survey every MRSA case in
detail, which may explain the higher prevalence found in this
study compared with the ﬁndings in Germany (11). However,
a high number of isolates of both MSSA and MRSA with the
FIG. 3. Pulsed-ﬁeld gel electrophoresis SmaI gel picture of t843
human and animal isolates from Slagelse Clinical Microbiological
Department and the United Kingdom. Lanes 1, 15 and 28: Lambda
size marker. Lanes 2, 14 and 27: NCTC8325. Lanes 3–13 and 16:
human samples from Slagelse. Lanes 17 and 21: animal owners. Lanes
18–20: S (sheep). Lane 22: C (cow). Lanes 23–24: human samples,
United Kingdom. Lanes 25–26: animal samples, United Kingdom.
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FIG. 2. Accumulated incidence of MRSA-mecC cases found in Danish
municipalities (2003–2011). The ﬁve major cities are shown: Copen-
hagen (Capital), Aarhus (Central Denmark), Aalborg (North Den-
mark), Odense and Esbjerg (South Denmark).
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various spa types detected in this study was found in the Ri-
dom spa server (http://spaserver.ridom.de/) and likewise
ovine, bovine and caprine isolates with sequence type (ST)
130, 151, 425, 1245 and 1526 from Norway, the Nether-
lands, Italy, Spain and the UK, are registered in the MLST
database. (http://www.MLST.net). These registrations indicate
that mecC-carrying MRSA may be more widely distributed,
but not recognized yet. Our search among bacteraemia
patients and healthy carriers only revealed a few MSSA spa
types (t528 and t1048, but none of the most frequent spa
type t843) associated with mecC. Further studies of S. aureus
carriage in ruminants could be of interest to conﬁrm if a
non-human reservoir of mecC MRSA exists in, for example,
cows or sheep.
The initial characterization of mecC-carrying MRSA strains
showed that they in general were susceptible to most other
classes of antibiotics. The lack of mecA detection could, how-
ever, have been associated with initial treatment failures
using, for example, dicloxacillin. In countries with an infection
control system where MRSA cases are registered based on
mecA conﬁrmation, a number of cases have deﬁnitely not
been recognized, resulting in a risk of continued spread. The
SCCmec XI element lacks non-beta-lactam resistance mecha-
nisms and the high susceptibility of these isolates is in accor-
dance with other bovine S. aureus, indicating that the
antimicrobial pressure is low (8). Penicillin is the preferred
antibiotic used in cattle in Denmark (22). The isolates there-
fore differ from LA-MRSA (CC398) isolates (related to pigs),
which are highly resistant to tetracycline and heavy metals
used in pig production.
Comparison of clinical data with those of CA-MRSA
showed differences regarding patient characteristics. For
example MRSA-mecC patients were older than other CA-
MRSA patients, indicating that mecC MRSA has a different
origin and epidemiology to typical CA-MRSA. We have pre-
viously reported a high degree of suggested import of CA-
MRSA in Denmark, as 35% of CA-MRSA patients were born
or had parents born outside Denmark (22). Among the
mecC-carrying MRSA, only six patients (5%) were found to
have a non-Danish origin, suggesting that import does not
contribute substantially to the emergence of mecC-carrying
MRSA in Denmark. The ﬁnding of mecC-carrying MRSA in
human, bovine and ovine samples indicates the existence of
several distinct reservoirs. The higher frequency of human
cases in rural areas compared with the capital region (Fig. 2)
may also indicate that contact with livestock could be a risk
factor for acquiring mecC-carrying MRSA whereas transmis-
sion via food is not. Possible zoonotic transmissions were
inferred from detection of seven human cases with bovine
or ovine contact and the subsequent ﬁnding of mecC-carry-
ing MRSA in animals with contact with two of the patients.
The carriage rate among tested animals conﬁrmed that only
a few animals in a cohort were colonized in the snouts (24).
Therefore sampling a larger number of animals in especially
North Denmark could possibly have resulted in ﬁndings of
mecC-carrying MRSA. We need comprehensive, veterinary
studies to specify the optimal sites for culture of S. aureus in
different animals. Early UK retrieval of MRSA-mecC in
pooled milk samples suggests that milk or udders should be
tested.
Furthermore, three patients carried MRSA-mecC for 2–
4 years and household transmission events were observed in
ﬁve cases (data not shown), indicating that mecC-carrying
MRSA are well adapted as human colonizers. However, in a
S. aureus collection from healthy carriers no isolates had spa
types matching the mecC-carrying isolates, pointing to a low
frequency.
Our results conﬁrm that ruminants (dairy cattle and
sheep) are healthy carriers of CC130 isolates and thus sub-
stantiate MRSA-mecC as a new zoonosis.
The range of infections caused by mecC-carrying MRSA is
the same as seen for other S. aureus, including life-threaten-
ing diseases such as bacteraemia.
In conclusion, we present the ﬁrst nationwide analysis of
the prevalence of S. aureus isolates carrying mecC, which
shows that the prevalence has increased in the last few
years and is now encompassing 2% of the annual human
MRSA cases in Denmark. The most recent and most com-
plete data from 1 August 2011 to 31 December 2011 indi-
cate that the frequency could be as high as 4%. The
detected isolates belonged to only two genetic lineages,
CC130 and CC2361. We found cows and sheep to be car-
rying mecC MRSA isolates and in two cases evidence sug-
gested transmission and development of bacteraemia and
skin infection in humans.
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